BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Policy

  Sun Pharmaceutical Industries Ltd Resolves Manufacturing Issues With FDA

  September 19, 2011

   · 

  1 min read
• Drug Development

  Amgen’s Prolia(R) (Denosumab) Phase 2 Extension Study Showed Continued Increase in Bone Mineral Density Over Eight Years of Treatment

  September 19, 2011

   · 

  13 min read
• Business

  Wright Medical Group, Inc. Names Robert J. Palmisano President and Chief Executive Officer

  September 19, 2011

   · 

  7 min read
• FDA

  Cellnovo Receives CE Mark Approval for World’s First Mobile Diabetes Management System

  September 19, 2011

   · 

  2 min read
• FDA

  OptiScan Biomedical Corporation Receives CE Mark for OptiScanner Automatic Bedside Glucose Monitoring System

  September 19, 2011

   · 

  6 min read
• Lone Star Bio

  Santé Ventures Gets $133.8 Million in Funding to Dump into Device Companies

  September 19, 2011

   · 

  1 min read
• BioMidwest

  Sunshine Heart Raises $7.4 Million in Two-Tranche Private Placement

  September 19, 2011

   · 

  4 min read
• GlucoTec, Inc. Completes Series A Preferred Stock Financing

  September 19, 2011

   · 

  2 min read
• Deals

  Bristol-Myers Squibb Company Pegged as Takeover Target, Bets on MS Drug to Hang Onto Its Gains

  September 19, 2011

   · 

  1 min read
• Drug Development

  Bristol-Myers Squibb Company’s Once-Daily Hepatitis C Drug Works in Phase II Study

  September 19, 2011

   · 

  5 min read